.Pharmacolibrary.Drugs.ATC.A.A10BH52 .Pharmacolibrary.Drugs.ATC.A.A10BH52| name: | GemigliptinAndRosuvastatin | |
| ATC code: | A10BH52 | route: | oral |
| compartments: | 1 | |
| dosage: | 50 | mg |
| volume of distribution: | 100 | L |
| clearance: | 14 | L/h |
| other parameters in model implementation | ||
Gemigliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor used for glycemic control in type 2 diabetes mellitus, while rosuvastatin is a statin medication used to lower cholesterol levels and prevent cardiovascular disease. The fixed-dose combination (ATC: A10BH52) is approved for co-management of hyperglycemia and hyperlipidemia in adults with type 2 diabetes and dyslipidemia.
No published population pharmacokinetic model found for the combination product. Pharmacokinetics are estimated from data for each drug in healthy adult subjects under fasting, oral administration conditions.